<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Journal of Surgical Oncology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Journal of Surgical Oncology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Journal+of+Surgical+Oncology&t=Journal+of+Surgical+Oncology&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 08:41:46 +0100</lastBuildDate>
        <item>
            <title>Living with rotationplasty—Quality of life in rotationplasty patients from childhood to adulthood</title>
            <link>http://www.medworm.com/index.php?rid=5666788&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22088</link>
            <description>ConclusionsThe assessment of QoL by the SF‐36 questionnaire was effective, and a correspondence was found between what emerged from the quantitative study and the contents of the interview. Knowing the strengths and weaknesses that were highlighted is indispensable for parents and operators when choosing among the various surgical options and to facilitate coming to terms with the injury and the “scars”. J. Surg. Oncol. 2012;105:331–336. © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666788</comments>
            <pubDate>Wed, 08 Feb 2012 13:16:21 +0100</pubDate>
            <guid isPermaLink="false">5666788</guid>        </item>
        <item>
            <title>Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?</title>
            <link>http://www.medworm.com/index.php?rid=5666787&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23044</link>
            <description>The objective of this study was to compare survival between all patients with radiographically resectable adenocarcinoma of the proximal pancreas who underwent preoperative chemoradiation therapy (PRE‐OP CRT) or surgical exploration first (SURGERY) with “intention to resect.” Pancreatic cancer patients who undergo resection after PREOP CRT live longer than patients who undergo resection without PREOP CRT, a difference that may be attributable to patient selection. We retrospectively identified 236 patients with pancreatic head adenocarcinoma seen between 1999 and 2007 with sufficient data to be confirmed medically and radiographically resectable. The outcomes of 144 patients who underwent PREOP CRT were compared to those of 92 patients who proceeded straight to SURGERY. The groups we...</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666787</comments>
            <pubDate>Wed, 08 Feb 2012 13:14:09 +0100</pubDate>
            <guid isPermaLink="false">5666787</guid>        </item>
        <item>
            <title>Adjuvant treatment of early colon cancer with micrometastases: Results of a national survey</title>
            <link>http://www.medworm.com/index.php?rid=5659447&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23057</link>
            <description>ConclusionsMM in colon cancer apparently influenced adjuvant treatment decisions absent known prognostic benefit. Prospective trials are needed to improve the selection of patients for systemic chemotherapy in early, node‐negative colon cancer. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659447</comments>
            <pubDate>Sun, 05 Feb 2012 13:13:44 +0100</pubDate>
            <guid isPermaLink="false">5659447</guid>        </item>
        <item>
            <title>Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5659448&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23047</link>
            <description>ConclusionsIn a cohort of patients undergoing a palliative bypass procedure, specific peri‐operative factors can be used to identify patients who are at risk of early mortality. These factors may be helpful in selecting appropriate interventions for this group of patients. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659448</comments>
            <pubDate>Fri, 03 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5659448</guid>        </item>
        <item>
            <title>High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases</title>
            <link>http://www.medworm.com/index.php?rid=5647106&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23058</link>
            <description>ConclusionsHigh dose SBRT for colorectal oligometastases was found to produce results comparable with surgical series. To improve local control, dose higher than 48 Gy are recommend when possible, but further study will be required to define the optimal normal tissue constraints and acceptable toxicity. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647106</comments>
            <pubDate>Thu, 02 Feb 2012 13:15:32 +0100</pubDate>
            <guid isPermaLink="false">5647106</guid>        </item>
        <item>
            <title>Follow‐up after primary treatment of soft tissue sarcoma of extremities: Impact of frequency of follow‐up imaging on disease‐specific survival</title>
            <link>http://www.medworm.com/index.php?rid=5647108&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23060</link>
            <description>ConclusionMore frequent follow‐up were associated with improved survival in high‐risk relapsing patients with extremity STS by providing greater opportunities for adequate reoperation. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647108</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5647108</guid>        </item>
        <item>
            <title>Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients</title>
            <link>http://www.medworm.com/index.php?rid=5647107&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23061</link>
            <description>ConclusionsPatients with stage IIB/III synovial sarcoma might benefit in DSS, MFS, and a prolonged TTM from AC. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647107</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5647107</guid>        </item>
        <item>
            <title>Brain metastasis from colorectal cancer: Prognostic factors and survival</title>
            <link>http://www.medworm.com/index.php?rid=5638164&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23055</link>
            <description>ConclusionsThe prognosis of patients with BM from CRC was associated with the curability of the therapy for BM, number of metastatic organs, and the serum CEA level. The modality of treatment had no significant impact on the outcome. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638164</comments>
            <pubDate>Sun, 29 Jan 2012 13:15:24 +0100</pubDate>
            <guid isPermaLink="false">5638164</guid>        </item>
        <item>
            <title>The flavonoid MonoHER prevents monocrotaline‐induced hepatic sinusoidal injury in rats</title>
            <link>http://www.medworm.com/index.php?rid=5638167&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23046</link>
            <description>ConclusionsMonoHER prevented MCT induced portal hypertension and hepatic injury in rats. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638167</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5638167</guid>        </item>
        <item>
            <title>High expression of CD73 as a poor prognostic biomarker in human colorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5638166&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23056</link>
            <description>ConclusionsHigh expression of CD73 can be an independent and useful biomarker for predicting the poor survival of patients with CRC. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638166</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5638166</guid>        </item>
        <item>
            <title>The promoting effect of adiponectin in hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5638165&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23059</link>
            <description>ConclusionsIncreased adiponectin expressions were found in HCC and this increase might contribute to tumor growth. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638165</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5638165</guid>        </item>
        <item>
            <title>Tumor spectrum in lynch syndrome, DNA mismatch repair system and endogenous carcinogens</title>
            <link>http://www.medworm.com/index.php?rid=5628138&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23054</link>
            <description>AbstractInactivation of Mismatch Repair genes in Lynch Syndrome, caused by inherited mutations, decreases the ability to repair DNA errors throughout life. This deficit may allow the development of any tumor type. Nevertheless, the Syndrome develops a specific tumor spectrum associated with the disease. We think that such spectrum of tumors would be related to the action of certain endogenous carcinogens such as bile acids and estrogens that aggravate the inherited defect. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628138</comments>
            <pubDate>Thu, 26 Jan 2012 13:16:10 +0100</pubDate>
            <guid isPermaLink="false">5628138</guid>        </item>
        <item>
            <title>Radiofrequency ablation combined with systemic chemotherapy in nasopharyngeal carcinoma liver metastases improves response to treatment and survival outcomes</title>
            <link>http://www.medworm.com/index.php?rid=5628139&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23034</link>
            <description>ConclusionsRFA combined with chemotherapy is a promising treatment for NPC metastatic liver disease with improved local response, PFS, and OS compared to current chemotherapy protocols. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628139</comments>
            <pubDate>Mon, 23 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5628139</guid>        </item>
        <item>
            <title>Free peritoneal tumor cells detection in gastric and colorectal cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=5608233&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23052</link>
            <description>ConclusionsEpithelial immunoenrichment and immunofluorescence analysis allows unequivocal identification of the FPTC. The real time qRT‐PCR showed higher sensitivity for the detection of CEA and CK20 mRNA levels and confirmed its prognostic value in gastrointestinal cancers. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608233</comments>
            <pubDate>Fri, 20 Jan 2012 13:16:52 +0100</pubDate>
            <guid isPermaLink="false">5608233</guid>        </item>
        <item>
            <title>Erratum: Relation of MT1‐MMP gene expression to outcomes in colorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5608238&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23043</link>
            <description>(Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608238</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608238</guid>        </item>
        <item>
            <title>Is transureteroureterostomy performed during multi‐organ resection for non‐urothelial malignancy safe and effective?</title>
            <link>http://www.medworm.com/index.php?rid=5608236&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23039</link>
            <description>ConclusionsTUU during multi‐organ resection for non‐urothelial malignancy is safe and effective. Long‐term renal function is maintained in the majority of patients. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608236</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608236</guid>        </item>
        <item>
            <title>Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5608235&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23048</link>
            <description>ConclusionsThe ARM technique is feasible in patients undergoing NAC. Patients with extensive nodal involvement have increased risk of having positive blue nodes. More studies are needed to assess the subgroup of patients with positive axilla that may have the blue node spared without compromising the oncological treatment. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608235</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608235</guid>        </item>
        <item>
            <title>Participation and conflict in the decision‐making process for endoscopic resection or surgical gastrectomy for early gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5608234&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23049</link>
            <description>ConclusionDespite the high overall decisional conflict, patients with preference for endoscopic treatment tended to be more autonomous. After consultation, all patients exhibited a passive participation role in the decision‐making process. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608234</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608234</guid>        </item>
        <item>
            <title>Malignant triton tumors—complete surgical resection and adjuvant radiotherapy associated with improved survival</title>
            <link>http://www.medworm.com/index.php?rid=5608241&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23042</link>
            <description>ConclusionComplete surgical resection and adjuvant radiotherapy should be the cornerstones of treatment for MTT. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608241</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608241</guid>        </item>
        <item>
            <title>Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5608240&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23051</link>
            <description>ConclusionsThe prognostic utility of occult tumor burden assessed by GUCY2C RT‐qPCR is dependent on the number of analytic lymph nodes. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608240</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608240</guid>        </item>
        <item>
            <title>Indocyanine green fluorescence‐navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false‐negative cases in skin cancer</title>
            <link>http://www.medworm.com/index.php?rid=5608239&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23045</link>
            <description>ConclusionICG‐FI detected SLNs more efficiently than did the conventional methods, and these “occult” SLNs may offer an explanation for some false‐negative cases. We recommend using ICG‐FI in addition to a conventional method to reduce the risk of overlooking these “occult” SLNs. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608239</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608239</guid>        </item>
        <item>
            <title>Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer</title>
            <link>http://www.medworm.com/index.php?rid=5581069&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23040</link>
            <description>ConclusionsHMGB1 might be a new molecular marker to predict the prognosis of patients with BC. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581069</comments>
            <pubDate>Fri, 13 Jan 2012 13:11:47 +0100</pubDate>
            <guid isPermaLink="false">5581069</guid>        </item>
        <item>
            <title>Improved guideline compliance after a 3‐year audit of multidisciplinary colorectal cancer care in the western part of the netherlands</title>
            <link>http://www.medworm.com/index.php?rid=5581072&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23038</link>
            <description>ConclusionsAfter the feedback of benchmark information, compliance with guidelines for diagnosis and treatment of colorectal cancer patients improved, and differences between individual hospitals decreased. Although secular trends cannot be ruled out, it is highly likely that these results can be attributed to the audit. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581072</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581072</guid>        </item>
        <item>
            <title>Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysis</title>
            <link>http://www.medworm.com/index.php?rid=5581071&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23036</link>
            <description>ConclusionThese data likely correlate with differences in molecular pathogenesis of HCC based on racial and regional differences. These findings may have implications in choice of molecular targeted therapies based on patient ethnicity. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581071</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581071</guid>        </item>
        <item>
            <title>Completeness of dictated operative reports in breast cancer—the case for synoptic reporting</title>
            <link>http://www.medworm.com/index.php?rid=5581070&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23031</link>
            <description>ConclusionsThe dictated operative report for breast cancer surgery does not adequately capture important data. A synoptic reporting system, which requires documentation of important elements, is a potentially beneficial tool in breast cancer surgery. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581070</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581070</guid>        </item>
        <item>
            <title>Overexpression of thrombospondin‐1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5581076&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23037</link>
            <description>ConclusionsThis clinical study revealed that overexpression of THBS‐1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma. THBS‐1 may activate latent transforming growth factor‐β1 to stimulate fibroblasts to differentiate into myofibroblasts, though further studies are needed to validate this hypothesis. These results suggest that THBS‐1 and myofibroblasts may serve as novel targets for strategies aimed at protection against and treatment of gastric carcinoma. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581076</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581076</guid>        </item>
        <item>
            <title>Abnormal expression of E‐cadherin in tumor cells is associated with poor prognosis of gastric carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5581075&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23008</link>
            <description>ConclusionWe found significant correlation among HGF/c‐Met, E‐cadherin expression and worse prognosis of patients with GC. Abnormal E‐cadherin expression may serve as an independent predictive factor for prognosis of GC patients. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581075</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581075</guid>        </item>
        <item>
            <title>Perioperative mortality in patients with myelodysplastic syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5581074&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23032</link>
            <description>ConclusionOutcomes in MDS patients are poor with expected survival less than 2 years and high postoperative mortality in the setting of urgent/emergent operations. While maybe not prohibitive, we believe it is an imperative part of the informed consent process particularly for urgent/emergent procedures. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581074</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581074</guid>        </item>
        <item>
            <title>Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection</title>
            <link>http://www.medworm.com/index.php?rid=5581073&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23033</link>
            <description>ConclusionsPerioperative change in peripheral blood monocyte count is an independent risk factor for overall survival after hepatic resection for CRLM, and may reflect immunosuppressive state. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581073</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581073</guid>        </item>
        <item>
            <title>Strong YB‐1 expression is associated with liver metastasis progression and predicts shorter disease‐free survival in advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5559505&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23030</link>
            <description>ConclusionsOur results indicate that YB‐1 plays a role in the process of GC metastasis, and that the immunohistochemical detection of this protein potentially delivers valuable insight regarding the prediction of liver metastasis and shorter DFS in patients undergoing curative resection for advanced GC. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559505</comments>
            <pubDate>Wed, 04 Jan 2012 17:41:38 +0100</pubDate>
            <guid isPermaLink="false">5559505</guid>        </item>
        <item>
            <title>Role of intraoperative ultrasonography for pancreatic schwannoma</title>
            <link>http://www.medworm.com/index.php?rid=5559507&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.21979</link>
            <description>(Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559507</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5559507</guid>        </item>
        <item>
            <title>Updates on the multimodality management of desmoplastic small round cell tumor</title>
            <link>http://www.medworm.com/index.php?rid=5559506&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22130</link>
            <description>AbstractDesmoplastic Small Round Cell Tumor (DSRCT) is a rare and an aggressive malignancy with poor outcome. This tumor can co‐express epithelial, neural, and mesenchymal markers. The molecular hallmark of DSRCT is the EWS–WT1 fusion protein. Despite the diversities in treatment modality, the best results have been seen with radical surgery and adjuvant or neoadjuvant chemotherapy. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559506</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5559506</guid>        </item>
        <item>
            <title>Down‐regulation of RhoE is associated with progression and poor prognosis in hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5552074&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23019</link>
            <description>ConclusionsRhoE, down‐regulated in patients with HCC, could serve as an independent prognostic predictor for patients with HCC. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552074</comments>
            <pubDate>Sat, 31 Dec 2011 01:44:10 +0100</pubDate>
            <guid isPermaLink="false">5552074</guid>        </item>
        <item>
            <title>Prognostic impact of tumor encapsulation in patients with large hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5552075&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23029</link>
            <description>(Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552075</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5552075</guid>        </item>
        <item>
            <title>Reirradiation to the pelvis for recurrent rectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5544227&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23023</link>
            <description>ConclusionsTumor location (axial or anterior) and surgery after reirradiation may increase severe late toxicity. In addition, an EQD2 exceeding 50 Gyαβ10 may improve infield control. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544227</comments>
            <pubDate>Wed, 28 Dec 2011 04:54:34 +0100</pubDate>
            <guid isPermaLink="false">5544227</guid>        </item>
        <item>
            <title>Primary surgical treatment of T2 oropharyngeal carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5544239&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23026</link>
            <description>ConclusionsPrimary surgical treatment of T2 OPC proved to be an effective treatment modality with a low rate of complications and satisfactory functional results. Complete tumor excision is essential and a neck dissection is justified. Most patients need adjuvant radiotherapy. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544239</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544239</guid>        </item>
        <item>
            <title>High‐grade osteosarcoma treated with hemicortical resection and biological reconstruction</title>
            <link>http://www.medworm.com/index.php?rid=5544238&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23005</link>
            <description>ConclusionsHemicortical resection for high‐grade osteosarcomas located eccentrically in the long bones may be a reliable technique leading to good joint function by preserving surrounding healthy tissues. The functional outcome was encouraging, although long‐term follow‐up is mandatory to validate. With the advancement of chemotherapy and radiographic three‐dimensional imaging, the safe margin in wide excision of high‐grade osteosarcoma may be narrowed down in light of joint surface preservation. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544238</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544238</guid>        </item>
        <item>
            <title>Routine prophylactic sentinel lymph node biopsy is not indicated in women undergoing prophylactic mastectomy</title>
            <link>http://www.medworm.com/index.php?rid=5544237&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23018</link>
            <description>ConclusionsAlthough it is not uncommon to find occult carcinomas in the prophylactic breast, it is rare for the occult carcinoma to spread to the lymph nodes. Therefore, routine prophylactic SLNB is not indicated in patients undergoing PM. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544237</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544237</guid>        </item>
        <item>
            <title>Clinicopathological prognostic factors of superficial non‐small round cell soft tissue sarcomas</title>
            <link>http://www.medworm.com/index.php?rid=5544236&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23025</link>
            <description>ConclusionsFascial invasion on pathological examination of resected specimens was identified as a significant unfavorable prognostic factor. Selecting the postoperative adjuvant therapy based on a detailed evaluation of any fascial invasion is an important part of the therapeutic strategy. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544236</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544236</guid>        </item>
        <item>
            <title>Primary excision compared with re‐excision of extremity soft tissue sarcomas—is anything new?</title>
            <link>http://www.medworm.com/index.php?rid=5544235&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23021</link>
            <description>ConclusionsThere were no differences in death, metastases, or local recurrence between the two groups after adjusting for high‐risk variables. Survival advantages previously reported with STS re‐excision serve as proxy for tumors that have a better survival profile. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544235</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544235</guid>        </item>
        <item>
            <title>Prognostic significance of lymph node station 7 for patients with gastric cancers underwent radical surgery</title>
            <link>http://www.medworm.com/index.php?rid=5544234&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23011</link>
            <description>ConclusionIt might be more suitable for cancers in Group B being classified as level‐based n1 stage disease. And we recommend the anatomical location of metastatic lymph nodes also being considered in the categorization of lymph node metastasis. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544234</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544234</guid>        </item>
        <item>
            <title>Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma</title>
            <link>http://www.medworm.com/index.php?rid=5544233&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23012</link>
            <description>ConclusionsThe overexpression of ZEB1 in osteosarcoma may be related to the carcinogenesis and development as well as metastasis and invasion of osteosarcoma. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544233</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544233</guid>        </item>
        <item>
            <title>Epithelial–mesenchymal transition and mesenchymal–epithelial transition via regulation of ZEB‐1 and ZEB‐2 expression in pancreatic cancer</title>
            <link>http://www.medworm.com/index.php?rid=5544232&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23020</link>
            <description>ConclusionsIn primary pancreatic tumors and metastatic lymph nodes, high and low expression of ZEB‐1 and ZEB‐2 was associated with mesenchymal and epithelial phenotype of cancer cells, respectively. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544232</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544232</guid>        </item>
        <item>
            <title>Composite biological reconstruction following total calcanectomy of primary calcaneal tumors</title>
            <link>http://www.medworm.com/index.php?rid=5544231&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23022</link>
            <description>ConclusionsVascularized fibular flaps in combination with massive allografts provide an excellent option for biological reconstruction after total calcanectomy in tumor situation and have proven to be a successful limb salvage procedure, which result in earlier patient recovery and return of function.Level of EvidenceTherapeutic Level IV. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544231</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544231</guid>        </item>
        <item>
            <title>Expression patterns of endothelin‐1 and its receptors in colorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5544230&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23017</link>
            <description>ConclusionsET‐1 and ETAR, but not ETBR, are expressed at a higher level in primary and cultured colon carcinoma cells as compared to normal colon mucosa cells. Further functional studies are needed to explore the role of ET‐1/ETAR axis in colon carcinogenesis. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544230</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544230</guid>        </item>
        <item>
            <title>Mechanism and function of decreased FOXO1 in renal cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5544229&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23013</link>
            <description>ConclusionReduced expression of FOXO1 is common in RCC and a potentially suitable marker of different histological subtypes and prognosis of cRCC. Increasing expression of FOXO1 by the miR‐27a inhibitor could prevent cell growth. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544229</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544229</guid>        </item>
        <item>
            <title>Comparison of radioguided occult lesion localization (ROLL) and wire localization for non‐palpable breast cancers: A meta‐analysis</title>
            <link>http://www.medworm.com/index.php?rid=5544228&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23016</link>
            <description>AbstractFour randomized trials encompassing 449 patients of non‐palpable breast cancer undergoing with radio‐guided occult lesion localization (ROLL) or wire guided localization (WGL). In the fixed effects model, accurate localization, peri‐procedural complications, and reoperation rate were comparable between two techniques. Risk of having positive resection margins following WGL was higher. Duration of localization and surgical excision was shorter for ROLL. Volume and weight of the excised occult breast lesion was similar in WGL and ROLL groups. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544228</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5544228</guid>        </item>
        <item>
            <title>Operative management for recurrent and metastatic adrenocortical carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5524182&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23015</link>
            <description>ConclusionsResection of recurrent or metastatic ACC is safe, and may result in prolongation of survival in selected patients with DFI greater than 1 year. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524182</comments>
            <pubDate>Thu, 22 Dec 2011 01:45:45 +0100</pubDate>
            <guid isPermaLink="false">5524182</guid>        </item>
        <item>
            <title>Neoadjuvant chemotherapy with FOLFOX: Improved outcomes in Chinese patients with locally advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5524184&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23009</link>
            <description>ConclusionPeri‐operative treatment with FOLFOX shows promise in patients with resectable locally advanced gastric cancer. It warrants further evaluation and should be considered an alternative to peri‐operative ECF. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524184</comments>
            <pubDate>Tue, 20 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5524184</guid>        </item>
        <item>
            <title>The decision criterion of histological mixed type in “T1/T2” gastric carcinoma—comparison between TNM classification and Japanese classification of gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5524183&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23010</link>
            <description>ConclusionsThe presence of undifferentiated component in differentiated T1/T2 gastric cancer is associated with tumor progression. Therefore, the decision criterion of histological mixed type in TNM classification is better suited than JCGC in T1/T2 gastric cancer. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524183</comments>
            <pubDate>Tue, 20 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5524183</guid>        </item>
        <item>
            <title>Preoperative serum value of sialyl Lewis X predicts pathological nodal extension and survival in patients with surgically treated small cell lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=5504396&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23002</link>
            <description>ConclusionsSerum SLX values were associated with pathological stage and survival after surgery in SCLC patients. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5504396</comments>
            <pubDate>Fri, 16 Dec 2011 01:46:20 +0100</pubDate>
            <guid isPermaLink="false">5504396</guid>        </item>
        <item>
            <title>The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5494663&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23007</link>
            <description>ConclusionsOf the various factors, the number of pathologic metastatic LNs was the strongest indicator to predict the patients' survival. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5494663</comments>
            <pubDate>Tue, 13 Dec 2011 01:50:33 +0100</pubDate>
            <guid isPermaLink="false">5494663</guid>        </item>
        <item>
            <title>Comparison of circumferential resection margin clearance criteria with survival after surgery for cancer of esophagus</title>
            <link>http://www.medworm.com/index.php?rid=5494665&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23006</link>
            <description>ConclusionThis study appears to lend credence to the RCP criteria for definition of CRM over the CAP criteria. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5494665</comments>
            <pubDate>Mon, 12 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5494665</guid>        </item>
        <item>
            <title>Self‐expanding metal stents (SEMS) for patients with advanced Esophageal cancer in Malawi: An effective palliative treatment</title>
            <link>http://www.medworm.com/index.php?rid=5494664&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23003</link>
            <description>ConclusionsSEMS is an appropriate palliative treatment in a resource‐limited environment. For the vast majority of patients a single intervention provides lasting improvement of dysphagia. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5494664</comments>
            <pubDate>Mon, 12 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5494664</guid>        </item>
        <item>
            <title>Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5486486&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22060</link>
            <description>ConclusionsTumor encapsulation is a significant prognostic factor for HCC &amp;gt;5 cm. J. Surg. Oncol. 2012; 105:85–90. © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486486</comments>
            <pubDate>Sat, 10 Dec 2011 01:55:39 +0100</pubDate>
            <guid isPermaLink="false">5486486</guid>        </item>
        <item>
            <title>Outcomes following oesophageal stent insertion for palliation of malignant strictures: A large single centre series</title>
            <link>http://www.medworm.com/index.php?rid=5486485&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22059</link>
            <description>ConclusionOesophageal stent insertion provides good palliation for malignant dysphagia, however recurrent dysphagia remains a problem. This major complication occurs more frequently with covered Niti S stents than double‐layered Niti S stents. This finding may aid the stent choice used in advanced oesophageal malignancy. J. Surg. Oncol. 2012; 105:60–65. © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486485</comments>
            <pubDate>Sat, 10 Dec 2011 01:55:33 +0100</pubDate>
            <guid isPermaLink="false">5486485</guid>        </item>
        <item>
            <title>Intravenous electrocardiography helps inexperienced operators to place totally implantable venous access device more accurately</title>
            <link>http://www.medworm.com/index.php?rid=5486484&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.23000</link>
            <description>ConclusionIV‐ECG is a safe and convenient method to help inexperienced operators placing TIVAD. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486484</comments>
            <pubDate>Sat, 10 Dec 2011 01:53:04 +0100</pubDate>
            <guid isPermaLink="false">5486484</guid>        </item>
        <item>
            <title>Estimating underreported N2 disease in rectal cancer patients with low lymph node counts</title>
            <link>http://www.medworm.com/index.php?rid=5468496&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22158</link>
            <description>ConclusionUtilizing estimated probabilities of N2 disease improves our ability to predict survival, in particular in patients with low LN count. These probabilities allow for a simple rule in patient counseling and clinical decision making. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5468496</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5468496</guid>        </item>
        <item>
            <title>Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: An alternative to surgery?</title>
            <link>http://www.medworm.com/index.php?rid=5457035&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22157</link>
            <description>ConclusionsThe results of the study do not support definitive CRT as an alternative to surgery in esophageal ADC treatment. Definitive CRT should be reserved for patients with a major operative risk. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5457035</comments>
            <pubDate>Thu, 01 Dec 2011 01:47:31 +0100</pubDate>
            <guid isPermaLink="false">5457035</guid>        </item>
        <item>
            <title>Reconstruction of the pulmonary trunk via cardiopulmonary bypass in extended resection of locally advanced lung malignancies</title>
            <link>http://www.medworm.com/index.php?rid=5457036&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22159</link>
            <description>ConclusionsCPB‐supported extended resection of lung malignancies involving the pulmonary trunk is feasible. Left anterolateral thoracotomy through the fourth intercostal space with right atrial‐aortic cannulation would be the convenient approach. Survival may be prolonged in some selected patients. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5457036</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5457036</guid>        </item>
        <item>
            <title>Nuclear localization of 14‐3‐3epsilon inversely correlates with poor long‐term survival of patients with colorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5431395&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22152</link>
            <description>ConclusionsThe current data provide evidence that 14‐3‐3ε is not exclusively a cytosolic protein, but is also detectable within the nucleus. Our results suggest that nuclear 14‐3‐3ε as a suppressor may serve as important biomarker of tumor metastasis. Loss of nuclear 14‐3‐3ε is closely associated with poor overall survival in CRC patients. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431395</comments>
            <pubDate>Tue, 22 Nov 2011 01:48:39 +0100</pubDate>
            <guid isPermaLink="false">5431395</guid>        </item>
        <item>
            <title>Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit from three‐field dissection in selected patients with thoracic esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5431401&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22148</link>
            <description>ConclusionsMetastasis to RLN LNs is a reliable indicator of cervical LN metastasis in middle/lower thoracic esophageal cancer, while 3FL offers survival benefit over 2FL in certain patient subgroups. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431401</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5431401</guid>        </item>
        <item>
            <title>Effect of surgeon specialization on long‐term survival following colon cancer resection at an NCI‐designated cancer center</title>
            <link>http://www.medworm.com/index.php?rid=5431400&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22154</link>
            <description>ConclusionSurgeon specialization appears to be associated with improved overall survival in the setting of an NCI‐designated cancer center. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431400</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5431400</guid>        </item>
        <item>
            <title>Clinical significance of MicoRNA‐155 expression in human breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5431399&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22153</link>
            <description>ConclusionsMiR‐155 expression might be an independent prognostic factor and a therapeutic target for human breast cancer. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431399</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5431399</guid>        </item>
        <item>
            <title>Aquaporins in human breast cancer: Identification and involvement in carcinogenesis of breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5431398&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22155</link>
            <description>ConclusionsThese observations suggested that several subtypes of the AQP family play a role in human breast carcinogenesis. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431398</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5431398</guid>        </item>
        <item>
            <title>Impact of lymph node retrieval on surgical outcomes in colorectal cancers</title>
            <link>http://www.medworm.com/index.php?rid=5431397&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22156</link>
            <description>ConclusionOur data emphasize the importance of lymph node harvesting during the surgical resection of CRCs. In addition, LNR is a strong independent factor associated with CRC survival. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431397</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5431397</guid>        </item>
        <item>
            <title>Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach</title>
            <link>http://www.medworm.com/index.php?rid=5431396&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22149</link>
            <description>ConclusionsSplenic hilar lymph node metastasis should be considered as one of incurable factors. Consequently, the efficiency of splenectomy aiming at prolonging survival for patients with high risk of splenic hilar lymph nodes metastasis should be questioned, although resection of invasive organs form gastric cancers has been recommended if R0 surgery could be achieved. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431396</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5431396</guid>        </item>
        <item>
            <title>The quality of life trajectory of resected gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5421675&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22139</link>
            <description>ConclusionsSurgery adversely affects QoL for up to 6 months. Thereafter, QoL mirrors changes in disease status. More studies are required to document the QoL cost‐benefit ratio in gastric cancer, which often is accompanied by short survival benefits. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421675</comments>
            <pubDate>Sat, 19 Nov 2011 01:46:22 +0100</pubDate>
            <guid isPermaLink="false">5421675</guid>        </item>
        <item>
            <title>Clinical significance of zinc finger E‐box binding homeobox 1 (ZEB1) in human gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5421681&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22142</link>
            <description>ConclusionsZEB1 is an independent factor for peritoneal dissemination in patients with gastric cancer, and may therefore play a key role in the progression to peritoneal dissemination in gastric cancer patients. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421681</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5421681</guid>        </item>
        <item>
            <title>Bilateral neck metastases in upper aero‐digestive tract cancer: Emphasis on the distribution of lymphatic metastases and prognostic implications</title>
            <link>http://www.medworm.com/index.php?rid=5421680&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22145</link>
            <description>ConclusionBNM at lower neck nodes can be a significant prognostic factor for early systemic dissemination and worse prognosis in UADTC patients. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421680</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5421680</guid>        </item>
        <item>
            <title>Evaluation of a hydrogel based breast biopsy marker (HydroMARK®) as an alternative to wire and radioactive seed localization for non‐palpable breast lesions</title>
            <link>http://www.medworm.com/index.php?rid=5421679&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22146</link>
            <description>ConclusionsWhile intraoperative sonographic visibility was excellent, a large number of excisions were associated with extrusion of the marker. Modifications are needed to improve acceptability of this marker for intra‐operative localization independent of pre‐operative wire or seed localization. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421679</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5421679</guid>        </item>
        <item>
            <title>Decreased expression of V‐set and immunoglobulin domain containing 1 (VSIG1) is associated with poor prognosis in primary gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5421678&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22150</link>
            <description>ConclusionsOur findings suggest that silencing VSIG1 may play an important role in gastric carcinogenesis and that VSIG1 may serve as a prognostic marker as well as a potential therapeutic target for gastric cancer. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421678</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5421678</guid>        </item>
        <item>
            <title>Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas</title>
            <link>http://www.medworm.com/index.php?rid=5421677&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22151</link>
            <description>ConclusionsOur findings provide a basis for the concept that decreased expression of Beclin 1 in GC may be important in the acquisition of a metastatic phenotype, suggesting that decreased Beclin 1 expression, as examined by IHC, is an independent biomarker for poor prognosis of patients with GC. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421677</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5421677</guid>        </item>
        <item>
            <title>A study of UbcH10 expression and its association with recurrence of meningiomas</title>
            <link>http://www.medworm.com/index.php?rid=5421676&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22141</link>
            <description>ConclusionWe conclude that UbcH10 may play important roles in the development of meningioma, high UbcH10 labeling index indicates higher grade of meningioma, and UbcH10 may be a useful molecular marker for predicting the prognosis of meningioma. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421676</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5421676</guid>        </item>
        <item>
            <title>Special considerations in pediatric gastrointestinal tumors</title>
            <link>http://www.medworm.com/index.php?rid=5400130&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.21868</link>
            <description>AbstractPediatric gastrointestinal tumors are rare in children but are being increasingly recognized. These tumors have distinct biologic and clinical feature that are different from those observed in adults. This review highlights the biological and clinical characteristics of pediatric GIST and provides diagnostic and therapeutic guidelines for the management these unique and challenging group of tumors. J. Surg. Oncol. 2011; 104:928–932. © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400130</comments>
            <pubDate>Sun, 13 Nov 2011 01:48:37 +0100</pubDate>
            <guid isPermaLink="false">5400130</guid>        </item>
        <item>
            <title>Surveillance strategies for gastrointestinal stromal tumors</title>
            <link>http://www.medworm.com/index.php?rid=5400129&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.21862</link>
            <description>AbstractAlthough only 10–30% of gastrointestinal stromal tumors (GISTs) are clinically malignant, all have some degree of malignant potential. The management of high risk patients should be evidence based. However, prospective data and a consensus for guidelines concerning the screening of asymptomatic high risk patients and surveillance following multidisciplinary treatment do not exist. This review provides an overview of GIST, with an emphasis on the available data regarding screening and surveillance of certain populations with GISTs. J. Surg. Oncol. 2011; 104:921–927. © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400129</comments>
            <pubDate>Sun, 13 Nov 2011 01:48:36 +0100</pubDate>
            <guid isPermaLink="false">5400129</guid>        </item>
        <item>
            <title>Imaging modalities of gastrointestinal stromal tumors</title>
            <link>http://www.medworm.com/index.php?rid=5400128&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.21871</link>
            <description>This article reviews the current roles of different imaging modalities in clinical management of the gastrointestinal stromal tumors. J. Surg. Oncol. 2011; 104:907–914. © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400128</comments>
            <pubDate>Sun, 13 Nov 2011 01:48:34 +0100</pubDate>
            <guid isPermaLink="false">5400128</guid>        </item>
        <item>
            <title>Systemic therapy for advanced gastrointestinal stromal tumors: Beyond imatinib</title>
            <link>http://www.medworm.com/index.php?rid=5400127&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.21872</link>
            <description>AbstractProgression on first‐line therapy with imatinib in gastrointestinal stromal tumors (GIST) is caused by either initial resistance or more often a secondary mutation in tyrosine kinases KIT or PDGFR. Therapies in development for imatinib‐resistant GIST include agents that target KIT/PDGFR with greater potency or possess broader kinase inhibition profiles including VEGFR. To circumvent secondary mutations in KIT/PDGFR, inhibition of the downstream signaling in PI3K/Akt/mTOR pathway and enhanced degradation of KIT/PDGFR are also under investigation. J. Surg. Oncol. 2011; 104:901–906. © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400127</comments>
            <pubDate>Sun, 13 Nov 2011 01:48:32 +0100</pubDate>
            <guid isPermaLink="false">5400127</guid>        </item>
        <item>
            <title>Adjuvant imatinib therapy for gastrointestinal stromal tumors</title>
            <link>http://www.medworm.com/index.php?rid=5400126&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22002</link>
            <description>AbstractSurgery is the standard of care for primary resectable gastrointestinal stromal tumors (GISTs), but half of surgically treated patients relapse. Imatinib (IM) has been shown to prolong recurrence‐free survival after complete surgery and is now approved as adjuvant therapy (400 mg/day) for high‐risk GIST patients. IM is well tolerated, with mild to moderate side effects observed. Whether adjuvant IM prolongs overall survival is under evaluation in two ongoing clinical trials. J. Surg. Oncol. 2011; 104:896–900. © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400126</comments>
            <pubDate>Sun, 13 Nov 2011 01:48:31 +0100</pubDate>
            <guid isPermaLink="false">5400126</guid>        </item>
        <item>
            <title>Advanced or metastatic gastrointestinal stromal tumors: Systemic treatment options</title>
            <link>http://www.medworm.com/index.php?rid=5400125&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.21930</link>
            <description>AbstractGastrointestinal stromal tumor (GIST), the most common sarcoma arising in the gastrointestinal tract, typically expresses the tyrosine‐kinase receptor, C‐KIT, and contains activating mutation in the c‐kit or platelet‐derived growth factor receptor (pdgfr) gene. Recently, development of small molecules that inhibit the kinase activity of mutant C‐KIT and PDGFR proteins has radically changed treatment and prognosis of patients diagnosed with advanced GIST as this molecularly “targeted” therapy has demonstrated remarkable high‐level of activity in this disease. J. Surg. Oncol. 2011; 104:888–895. © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400125</comments>
            <pubDate>Sun, 13 Nov 2011 01:48:30 +0100</pubDate>
            <guid isPermaLink="false">5400125</guid>        </item>
        <item>
            <title>Morphology of gastrointestinal stromal tumors: Historical perspectives</title>
            <link>http://www.medworm.com/index.php?rid=5400124&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.21873</link>
            <description>AbstractAbout 2/3 of gastrointestinal stromal tumors occur in the stomach and about 1/5 in the small intestine with few in the rectum, colon, and esophagus. Their cells are related to the interstitial cells of Cajal. They differ by site in terms of cell type and growth pattern. Benign and malignant tumors are separated based on their light microscopic appearances, size as measured by innumerable pathologists and assistants and mitotic counts. J. Surg. Oncol. 2011; 104:874–881. © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400124</comments>
            <pubDate>Sun, 13 Nov 2011 01:48:28 +0100</pubDate>
            <guid isPermaLink="false">5400124</guid>        </item>
        <item>
            <title>Histopathology of gastrointestinal stromal tumor</title>
            <link>http://www.medworm.com/index.php?rid=5400123&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.21945</link>
            <description>AbstractGastrointestinal stromal tumor (GIST), generally driven by oncogenic KIT or PDGFRA mutations, is the most common mesenchymal tumor of the gastrointestinal (GI) tract. GIST is most common in the stomach (60%) and small intestine (30%), but can occur anywhere in the GI‐tract and the intra‐abdominal soft tissues. GIST can show spindle cell or epithelioid morphology, and mitotic count and tumor size are most important prognostic parameters. GISTs in NF1 patients and children are distinctive clinicopathologic groups. Immunohistochemical testing for KIT and sometimes for DOG1/Ano 1 is essential in confirming the diagnosis. J. Surg. Oncol. 2011; 104:865–873. © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400123</comments>
            <pubDate>Sun, 13 Nov 2011 01:48:26 +0100</pubDate>
            <guid isPermaLink="false">5400123</guid>        </item>
        <item>
            <title>The molecular evolution of surgical oncology</title>
            <link>http://www.medworm.com/index.php?rid=5400122&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22050</link>
            <description>(Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400122</comments>
            <pubDate>Sun, 13 Nov 2011 01:48:25 +0100</pubDate>
            <guid isPermaLink="false">5400122</guid>        </item>
        <item>
            <title>Tribute to Alfred E. Chang</title>
            <link>http://www.medworm.com/index.php?rid=5400121&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22036</link>
            <description>(Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400121</comments>
            <pubDate>Sun, 13 Nov 2011 01:48:24 +0100</pubDate>
            <guid isPermaLink="false">5400121</guid>        </item>
        <item>
            <title>The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus‐related hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5400113&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22137</link>
            <description>ConclusionsCareful control of plasma glucose should be performed to prevent tumor recurrence after curative resection for HCV‐related HCC in patients with diabetes. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400113</comments>
            <pubDate>Sun, 13 Nov 2011 01:46:21 +0100</pubDate>
            <guid isPermaLink="false">5400113</guid>        </item>
        <item>
            <title>Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5400119&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22134</link>
            <description>ConclusionTargeting survivin will be a potential strategy to suppress metastasis of CRC. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400119</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5400119</guid>        </item>
        <item>
            <title>Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy</title>
            <link>http://www.medworm.com/index.php?rid=5400118&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22136</link>
            <description>ConclusionsPostoperative chemotherapy using TP might be more beneficial for survival than adjuvant RT and can reduce postoperative complications for cervical cancer patients treated with radical hysterectomy. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400118</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5400118</guid>        </item>
        <item>
            <title>Prognostic values of the miR‐17‐92 cluster and its paralogs in colon cancer</title>
            <link>http://www.medworm.com/index.php?rid=5400117&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22138</link>
            <description>ConclusionsThe miR‐17‐92 cluster and its paralogs were significantly elevated in patients with colon cancer, and heightened expression of miR‐17 was associated with poor survival. Moreover, miR‐17 and TNM staging were both identified as significant, but independent, prognostic biomarkers in colon cancer. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400117</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5400117</guid>        </item>
        <item>
            <title>Influence of uncommon histology on breast conservation therapy for breast cancer‐biology dictates technique?</title>
            <link>http://www.medworm.com/index.php?rid=5400116&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22132</link>
            <description>ConclusionsPatients with uncommon breast cancer histologies show wide variation in the application of BCT depending on the primary tumor. This suggests that an individualized approach in the use of BCT depending on histology should be used. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400116</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5400116</guid>        </item>
        <item>
            <title>Peri‐operative chemotherapy for resectable colorectal liver metastasis: Does timing of systemic therapy matter?</title>
            <link>http://www.medworm.com/index.php?rid=5400115&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22133</link>
            <description>ConclusionPre‐operative chemotherapy was associated with a trend toward increased morbidity among patients undergoing a major hepatic resection. Receipt of pre‐operative chemotherapy was associated with neither an advantage nor disadvantage in terms of long‐term survival. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400115</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5400115</guid>        </item>
        <item>
            <title>A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline‐containing neoadjuvant chemotherapy for breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5400114&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22140</link>
            <description>ConclusionOur prognostic model could easily discriminate patients with different risks of experiencing an event or death, which could allow physicians to tailor treatment strategies specifically and individually. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400114</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5400114</guid>        </item>
        <item>
            <title>Identification of the a kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5400120&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22135</link>
            <description>ConclusionsThe current data suggest that AKAP12 is downregulated in cancer tissues through promoter hypermethylation, and may have a role as a candidate tumor suppressor gene for HCC. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400120</comments>
            <pubDate>Thu, 03 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5400120</guid>        </item>
        <item>
            <title>The changing landscape of axillary surgery: Which breast cancer patients may still benefit from complete axillary lymph node dissection?</title>
            <link>http://www.medworm.com/index.php?rid=5360037&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22131</link>
            <description>ConclusionA SLN+ biopsy by FS predicts the presence of NSLN metastases and, in combination with other factors, may justify immediate CALND. CALND may, however, be avoided in selected low‐risk SLN+ patients. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5360037</comments>
            <pubDate>Mon, 31 Oct 2011 00:20:27 +0100</pubDate>
            <guid isPermaLink="false">5360037</guid>        </item>
        <item>
            <title>Atypical fibroxanthoma: Clinicopathologic determinants for recurrence and implications for surgical management</title>
            <link>http://www.medworm.com/index.php?rid=5346966&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22128</link>
            <description>ConclusionsWhile the majority of AFX presentations are benign, there is a real possibility of metastatic spread. Invasion beyond the dermis and a rapid rate of recurrence are suggestive of a more aggressive clinical course. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5346966</comments>
            <pubDate>Wed, 26 Oct 2011 05:45:37 +0100</pubDate>
            <guid isPermaLink="false">5346966</guid>        </item>
        <item>
            <title>Perioperative and long‐term results of laparoscopic spleen‐preserving distal pancreatectomy with or without splenic vessels conservation: A retrospective analysis</title>
            <link>http://www.medworm.com/index.php?rid=5346968&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22117</link>
            <description>ConclusionLaparoscopic spleen‐preserving distal pancreatectomy is feasible. A moderate risk of postoperative splenic infarction has to be taken into account, and the formation of perigastric varices may be interpreted as a paraphysiologic phenomenon, especially after splenic vessels resection. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5346968</comments>
            <pubDate>Mon, 24 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5346968</guid>        </item>
        <item>
            <title>Elevated high‐sensitivity C‐reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence</title>
            <link>http://www.medworm.com/index.php?rid=5346967&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22129</link>
            <description>ConclusionElevated preoperative hs‐CRP levels in gastric cancer patients are clinically significant indicators of advanced stage and postoperative disease recurrence. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5346967</comments>
            <pubDate>Mon, 24 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5346967</guid>        </item>
        <item>
            <title>Isolated limb perfusion with TNF‐alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients</title>
            <link>http://www.medworm.com/index.php?rid=5335218&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22121</link>
            <description>ConclusionWith a limb salvage rate of 87%, TM‐ILP is an effective treatment modality in patients with distal STS. In all patients with an indication for amputation surgery due to an STS in the distal part of the limb, TM‐ILP should be considered. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335218</comments>
            <pubDate>Sat, 22 Oct 2011 00:50:04 +0100</pubDate>
            <guid isPermaLink="false">5335218</guid>        </item>
        <item>
            <title>Oncofetal protein, IMP‐3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5335221&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22108</link>
            <description>ConclusionsIMP‐3 expression in primary gastric tumors was an independent poor prognostic factor. IMP‐3 mRNA expression in peritoneal lavage fluid was a predictor of recurrence after surgery in gastric cancer and a marker of poor prognosis. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335221</comments>
            <pubDate>Wed, 19 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5335221</guid>        </item>
        <item>
            <title>Post‐radiation sarcomas. Clinical outcome of 52 Patients</title>
            <link>http://www.medworm.com/index.php?rid=5335220&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22122</link>
            <description>ConclusionsPrognosis of post‐radiation sarcomas is poor; the type of the sarcomas is the only significant variable for survival. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335220</comments>
            <pubDate>Wed, 19 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5335220</guid>        </item>
        <item>
            <title>A phase I/II clinical trial of preoperative short‐course carbon‐ion radiotherapy for patients with squamous cell carcinoma of the esophagus</title>
            <link>http://www.medworm.com/index.php?rid=5335219&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22127</link>
            <description>ConclusionsCIR showed strong local tumor control and is highly effective as a neoadjuvant therapy without severe adverse events. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335219</comments>
            <pubDate>Wed, 19 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5335219</guid>        </item>
        <item>
            <title>Liver‐directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery</title>
            <link>http://www.medworm.com/index.php?rid=5323743&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22114</link>
            <description>ConclusionA multimodality approach towards treatment of disease progression as shown in this study that includes repeat surgery or radioembolization has been shown to achieve a superior outcome in the setting of disease progression/recurrence. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323743</comments>
            <pubDate>Tue, 18 Oct 2011 00:54:47 +0100</pubDate>
            <guid isPermaLink="false">5323743</guid>        </item>
        <item>
            <title>Efficacy of pre‐operative chemotherapy with docetaxel, cisplatin, and S‐1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para‐aortic lymph nodes</title>
            <link>http://www.medworm.com/index.php?rid=5323751&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22125</link>
            <description>ConclusionMultimodal therapy comprising combined pre‐operative DCS therapy and gastrectomy with PAND was extremely effective and feasible for advanced gastric cancer with PAN metastasis. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323751</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5323751</guid>        </item>
        <item>
            <title>Pretreatment risk factors for multiple gastric cancer and missed lesions</title>
            <link>http://www.medworm.com/index.php?rid=5323750&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22124</link>
            <description>ConclusionPhysicians should keep pretreatment risk factors for MGC in mind to avoid missing a synchronous lesion. Meticulous examination is required after a detection of large‐sized main lesion. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323750</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5323750</guid>        </item>
        <item>
            <title>Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes</title>
            <link>http://www.medworm.com/index.php?rid=5323749&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22118</link>
            <description>ConclusionsWhen controlled for other established prognostic parameters, histopathologic subtype assignment of pancreatic ICTs affects survival prediction. Resection is associated with superior survival for all tumor types. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323749</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5323749</guid>        </item>
        <item>
            <title>Increased expression of fibroblastic growth factor receptor 2 is correlated with poor prognosis in patients with breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5323748&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22120</link>
            <description>ConclusionsHigh FGFR2 expression is correlated with poor OS and DFS in breast cancer patients. It could be a biomarker for poor prognosis. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323748</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5323748</guid>        </item>
        <item>
            <title>TS and DPD mRNA levels on formalin‐fixed paraffin‐embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5323747&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22123</link>
            <description>ConclusionsHigh TS and DPD mRNA levels on FFPE specimens may predict distant recurrence of rectal cancer treated with 5‐FU‐based preoperative CRT followed by surgery. Expression analysis of 5‐FU metabolizing enzyme in residual cancer may be useful for treatment stratification and clinical management in these patients. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323747</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5323747</guid>        </item>
        <item>
            <title>Targeting the proteasome as a promising therapeutic strategy in thyroid cancer</title>
            <link>http://www.medworm.com/index.php?rid=5323746&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22113</link>
            <description>ConclusionProteasome inhibition is effective in reducing cell growth and inducing apoptosis of ATC in vitro and inhibiting tumor growth and vascularity in vivo. However, the impact on nuclear transcription remains controversial. Clinical evaluation of bortezomib treatment in ATC is warranted. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323746</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5323746</guid>        </item>
        <item>
            <title>The role of preoperative neck ultrasounds to assess lymph nodes in patients with suspicious or indeterminate thyroid nodules</title>
            <link>http://www.medworm.com/index.php?rid=5323745&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22115</link>
            <description>ConclusionThyroid nodule microcalcifications on ultrasound and category of FNAB appear to be the best predictors of metastatic disease. Because the surgical approach was altered in only a few patients, further analysis is needed to delineate whether performing cervical ultrasound for suspicious/indeterminate nodules is cost effective. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323745</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5323745</guid>        </item>
        <item>
            <title>Adding surgery as a complementary approach to radioiodine therapy in patients of differentiated thyroid carcinoma with large solitary flat bone metastases: the unresolved issues</title>
            <link>http://www.medworm.com/index.php?rid=5323744&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22116</link>
            <description>(Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323744</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5323744</guid>        </item>
        <item>
            <title>The effect of postoperative pelvic irradiation after complete resection of metastatic rectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5304120&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22109</link>
            <description>ConclusionsSurvival benefit of postoperative RTx in stage IV rectal cancer after complete removal of tumors was not apparent. RTx could be recommended for selected patients at high risk of local recurrence or for palliation of symptoms. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304120</comments>
            <pubDate>Wed, 12 Oct 2011 00:53:37 +0100</pubDate>
            <guid isPermaLink="false">5304120</guid>        </item>
        <item>
            <title>Prevention of lymphocele in female pelvic lymphadenectomy by a collagen patch coated with the human coagulation factors: A pilot study</title>
            <link>http://www.medworm.com/index.php?rid=5304121&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22110</link>
            <description>ConclusionsIntraoperative application of TachoSil reduced rate of postoperative lymphocysts after PL, and it seems to provide a useful additional treatment option for reducing drainage volume and preventing lymphocele development after PL. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304121</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5304121</guid>        </item>
        <item>
            <title>Multidisciplinary management of malignant pleural effusion</title>
            <link>http://www.medworm.com/index.php?rid=5273294&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22100</link>
            <description>AbstractApproximately 50% of patients with metastatic disease develop a malignant pleural effusion (MPE). Prompt clinical evaluation and treatment to achieve successful palliation are the main goals of management of MPE. Optimal treatment is still controversial and there is no universal standard approach. Management options include observation, thoracentesis, indwelling pleural catheter (IPC) or chest tube placement, pleurodesis, and surgical pleurectomy. The treatment for each patient should be based on symptoms, general condition, and life expectancy. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5273294</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5273294</guid>        </item>
        <item>
            <title>Kyphoplasty in patients with multiple myeloma a retrospective comparative pilot study</title>
            <link>http://www.medworm.com/index.php?rid=5273296&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22101</link>
            <description>ConclusionAdditional kyphoplasty was more effective than additional radiation or systemic therapy in terms of pain relief, reduction of pain associated disability and reduction of fracture incidence of the entire lumbar and thoracic spine. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5273296</comments>
            <pubDate>Thu, 29 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5273296</guid>        </item>
        <item>
            <title>Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: Evaluation of radiological and pathological response</title>
            <link>http://www.medworm.com/index.php?rid=5273295&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22104</link>
            <description>ConclusionSBRT achieves total or partial radiological response in 37% of patients and total or partial pathological response in 37% of patients with early HCC in the setting of cirrhosis. SBRT may be a safe and effective alternative for local tumor control in patients with HCC and cirrhosis awaiting OLT. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5273295</comments>
            <pubDate>Thu, 29 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5273295</guid>        </item>
        <item>
            <title>Comparison of surgical outcomes between endoscopic and robotic thyroidectomy</title>
            <link>http://www.medworm.com/index.php?rid=5260210&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22106</link>
            <description>ConclusionRobotic thyroidectomy was lengthier in duration than endoscopic thyroidectomy, more costly, and associated with increased postoperative drainage with no improvement in oncologic outcomes or complication rates. Therefore our data do not support any advantage of robotic surgery over endoscopic surgery. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5260210</comments>
            <pubDate>Thu, 29 Sep 2011 00:51:02 +0100</pubDate>
            <guid isPermaLink="false">5260210</guid>        </item>
        <item>
            <title>Potent antitumour activity of the combination of HSV‐TK and endostatin armed oncolytic adeno‐associated virus for bladder cancer in vitro and in vivo</title>
            <link>http://www.medworm.com/index.php?rid=5260213&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22107</link>
            <description>ConclusionsWe concluded that the inhibition of angiogenesis using Endostatin gene transfer, together with the cytotoxicity HSV‐TK gene therapy, resulted in a significant antitumour effect compared to the single gene based therapy in BTCC. The results warrant further development of the combination gene therapy, and suggest that this approach, directed towards systemic efficiency, could be used as an additional treatment for human BTCC. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5260213</comments>
            <pubDate>Tue, 27 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5260213</guid>        </item>
        <item>
            <title>Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer</title>
            <link>http://www.medworm.com/index.php?rid=5260212&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22102</link>
            <description>ConclusionThis study demonstrates the feasibility of optical imaging of oral squamous cell carcinoma based on targeting of αvβ3 integrins and the EPR effect. Once these NIR fluorescence agents become available for clinical testing, optical image‐guided surgery could reduce residual disease after oral cancer surgery. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5260212</comments>
            <pubDate>Tue, 27 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5260212</guid>        </item>
        <item>
            <title>Ten‐year survival of esophageal cancer after an en‐bloc esophagectomy</title>
            <link>http://www.medworm.com/index.php?rid=5260211&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22096</link>
            <description>ConclusionPatients with locally advanced disease, managed by a multidisciplinary treatment strategy, achieved a similar long‐term survival to patients with early disease (stadium I + II). J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5260211</comments>
            <pubDate>Tue, 27 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5260211</guid>        </item>
        <item>
            <title>Meta‐analysis of laparoscopy‐assisted distal gastrectomy with D2 lymph node dissection for gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5250372&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22098</link>
            <description>ConclusionsCompared with ODG, LADG with D2 dissection has the advantages of minimal invasion, faster recovery, and fewer complications, and it can achieve the same degree of radicality and short‐term prognosis as ODG. The drawbacks are that the operating time is slightly longer and long‐term prognosis is not clear. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5250372</comments>
            <pubDate>Sun, 25 Sep 2011 08:54:49 +0100</pubDate>
            <guid isPermaLink="false">5250372</guid>        </item>
        <item>
            <title>Primary liver cancer presenting as pyogenic liver abscess: Characteristics, diagnosis, and management</title>
            <link>http://www.medworm.com/index.php?rid=5250375&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22103</link>
            <description>ConclusionsElevated AFP and CA19‐9 could suggest HCC and IHCC in patients with symptoms/signs typical of PLA. Contrast‐enhanced computed tomography could be helpful in patients with normal AFP and CA19‐9. Making an accurate and early diagnosis and seizing the opportunity of surgery are essential to improve the management strategies of patients with PLC mimicking PLA. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5250375</comments>
            <pubDate>Thu, 22 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5250375</guid>        </item>
        <item>
            <title>Impact of perineal pseudocontinent colostomy on perineal wound healing after abdominoperineal resection</title>
            <link>http://www.medworm.com/index.php?rid=5250374&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22105</link>
            <description>ConclusionsPPC accelerates perineal wound healing after APR without decreasing the overall perineal complication rate. J. Surg. Oncol © 2011 Wiley Periodicals, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5250374</comments>
            <pubDate>Thu, 22 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5250374</guid>        </item>
        <item>
            <title>A retrospective study of surgical treatment of chronic radiation enteritis</title>
            <link>http://www.medworm.com/index.php?rid=5236869&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22099</link>
            <description>ConclusionsSurgery is justified for patients with bowel obstruction or fistula after CRE. A comprehensive perioperative management, especially perioperative nutrition therapy was important for the success of the surgery. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5236869</comments>
            <pubDate>Wed, 21 Sep 2011 17:36:48 +0100</pubDate>
            <guid isPermaLink="false">5236869</guid>        </item>
        <item>
            <title>Differential expression of sprouty genes in hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5236871&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22095</link>
            <description>ConclusionThis study demonstrates that Sprouty genes are differentially expressed in HCC and might provide some insight into their roles in HCC carcinogenesis. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5236871</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5236871</guid>        </item>
        <item>
            <title>High phosphorylated 4E‐binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients</title>
            <link>http://www.medworm.com/index.php?rid=5236870&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22097</link>
            <description>Conclusion High p‐4E‐BP1 expression after CRT is a predictor for LR and worse survival in esophageal SCC patients. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5236870</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5236870</guid>        </item>
        <item>
            <title>Axillary reverse mapping using a fluorescence imaging system in breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5207979&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22094</link>
            <description>ConclusionsIt may be feasible to spare ARM nodes during ALND in patients with positive SLN. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5207979</comments>
            <pubDate>Mon, 12 Sep 2011 18:01:10 +0100</pubDate>
            <guid isPermaLink="false">5207979</guid>        </item>
        <item>
            <title>Cutaneous apocrine adenocarcinoma: Defining epidemiology, outcomes, and optimal therapy for a rare neoplasm</title>
            <link>http://www.medworm.com/index.php?rid=5207981&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22023</link>
            <description>ConclusionsCutaneous apocrine adenocarcinoma is a rare neoplasm. Excision is standard treatment. The most important predictor of survival in localized disease is lymph node status; therefore, sentinel lymph node biopsy could be considered in management of this disease. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5207981</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5207981</guid>        </item>
        <item>
            <title>Clinical decision‐making and implementation challenges with the AJCC VII staging system for colorectal carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5207980&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22086</link>
            <description>(Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5207980</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5207980</guid>        </item>
        <item>
            <title>Anti‐cancer agents for breast cancer treatment during pregnancy</title>
            <link>http://www.medworm.com/index.php?rid=5196125&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.21951</link>
            <description>(Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5196125</comments>
            <pubDate>Tue, 06 Sep 2011 17:45:05 +0100</pubDate>
            <guid isPermaLink="false">5196125</guid>        </item>
        <item>
            <title>Response to letter to the editor</title>
            <link>http://www.medworm.com/index.php?rid=5196124&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.21950</link>
            <description>(Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5196124</comments>
            <pubDate>Tue, 06 Sep 2011 17:45:04 +0100</pubDate>
            <guid isPermaLink="false">5196124</guid>        </item>
        <item>
            <title>Long‐term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology</title>
            <link>http://www.medworm.com/index.php?rid=5196121&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22091</link>
            <description>ConclusionsA Borrmann type IV carcinoma may be the candidates for intraperitoneal chemotherapy among advanced gastric cancer patients. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5196121</comments>
            <pubDate>Tue, 06 Sep 2011 17:42:43 +0100</pubDate>
            <guid isPermaLink="false">5196121</guid>        </item>
        <item>
            <title>B lymphocytes as effector cells in the immunotherapy of cancer</title>
            <link>http://www.medworm.com/index.php?rid=5196123&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22093</link>
            <description>AbstractOver the years, the role of B cells in the host immune response to malignancy has been overshadowed by our focus on T cells. Nevertheless, B cells play important roles as antigen‐presenting cells and in the production of antibodies. Furthermore, B cells can function as effector cells that mediate tumor destruction on their own. This review will highlight the various functions of B cells that are involved in the host response to tumor. J. Surg. Oncol. © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5196123</comments>
            <pubDate>Mon, 05 Sep 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5196123</guid>        </item>
        <item>
            <title>Survival analysis of gastric cancer patients with tumor thrombus in the portal vein</title>
            <link>http://www.medworm.com/index.php?rid=5196122&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22083</link>
            <description>ConclusionsPVTT originating from gastric cancer was a poor prognostic factor and the median survival from PVTT was different according to several clinical factors. J. Surg. Oncol. © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5196122</comments>
            <pubDate>Mon, 05 Sep 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5196122</guid>        </item>
        <item>
            <title>Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer</title>
            <link>http://www.medworm.com/index.php?rid=5183440&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22090</link>
            <description>ConclusionsAn advanced T stage, nodal metastasis, poor differentiation, and the pancreaticobiliary type were found to be independent predictors of recurrence after curative resection of ampullary carcinoma by multivariate analysis. In addition, the pancreatobiliary type tended to present in a more advanced T stage and more frequently with regional lymph node involvement and perineural invasion than the intestinal type. Furthermore, CEA level and lymph node metastasis were found to be independent predictors of recurrence for the intestinal and pancreatobiliary types, respectively. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183440</comments>
            <pubDate>Wed, 31 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183440</guid>        </item>
        <item>
            <title>Implementation of educational video improves patient understanding of basic breast cancer concepts in an undereducated county hospital population</title>
            <link>http://www.medworm.com/index.php?rid=5183445&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22046</link>
            <description>ConclusionsImplementation of an educational video significantly improved understanding of breast cancer concepts in an undereducated population. J. Surg. Oncol. © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183445</comments>
            <pubDate>Tue, 30 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183445</guid>        </item>
        <item>
            <title>Gastric cancer: Biology and clinical manifestations in Israel</title>
            <link>http://www.medworm.com/index.php?rid=5183444&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22078</link>
            <description>ConclusionThere do not appear to be any major differences in the biology or clinical manifestations of GC in Israel. Western recommendations for diagnosis and treatment of GC may therefore be applied to the Israeli patient population. J. Surg. Oncol. © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183444</comments>
            <pubDate>Tue, 30 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183444</guid>        </item>
        <item>
            <title>Controversies in parathyroid surgery: The quest for a “mini” unilateral parathyroid operation seems to have gone too far</title>
            <link>http://www.medworm.com/index.php?rid=5183443&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22040</link>
            <description>(Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183443</comments>
            <pubDate>Tue, 30 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183443</guid>        </item>
        <item>
            <title>Intraperitoneal docetaxel combined with S‐1 for advanced gastric cancer with peritoneal dissemination</title>
            <link>http://www.medworm.com/index.php?rid=5183442&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22057</link>
            <description>ConclusionThis study indicated that the NIPS combined with surgery was highly active and well tolerated by advanced gastric cancer patients with PC. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183442</comments>
            <pubDate>Tue, 30 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183442</guid>        </item>
        <item>
            <title>Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5183441&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22085</link>
            <description>ConclusionsThis study suggests that both tumor differentiation and tumor size is the most important clinical predicator of pathologic tumor response, it may be of benefit in the selection of treatment options in locally advanced gastric cancer. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183441</comments>
            <pubDate>Tue, 30 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183441</guid>        </item>
        <item>
            <title>Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients</title>
            <link>http://www.medworm.com/index.php?rid=5183450&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22068</link>
            <description>ConclusionTumor PP immunoreactivity in conjunction with CRM status are useful markers to identify aggressive post‐CRT treated ypT3N0 stage esophageal SCC. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183450</comments>
            <pubDate>Mon, 29 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183450</guid>        </item>
        <item>
            <title>Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node‐negative gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5183449&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22089</link>
            <description>ConclusionsIn pN0 gastric cancers, prognostic factors differed significantly between early stage and advanced stage. For patients with pT3, besides curative gastrectomy and postoperative chemotherapy, it might be beneficial to perform intraoperative chemotherapy and extensive lymphadenectomy. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183449</comments>
            <pubDate>Mon, 29 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183449</guid>        </item>
        <item>
            <title>Down‐regulated SPARCL1 is associated with clinical significance in human gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5183448&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22025</link>
            <description>ConclusionsOur study revealed the clinical significance of SPARCL1 expression, providing a basis that the loss of SPARCL1 is a negative event in GC progression and prognosis. Furthermore, SPARCL1 protein might be considered to be a potential differentiation marker. J. Surg. Oncol. © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183448</comments>
            <pubDate>Mon, 29 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183448</guid>        </item>
        <item>
            <title>Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5183447&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22081</link>
            <description>ConclusionsUrachal adenocarcinoma with peritoneal dissemination is an aggressive, rare disease, which is uniformly fatal. In our experience, CRS followed by HIPEC with Mitomycin C may increase patient survival and palliation, although further treatment improvements are clearly required. J. Surg. Oncol. © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183447</comments>
            <pubDate>Mon, 29 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183447</guid>        </item>
        <item>
            <title>RUNX3 methylation as a predictor for disease progression in patients with non‐muscle‐invasive bladder cancer</title>
            <link>http://www.medworm.com/index.php?rid=5183446&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22087</link>
            <description>ConclusionsRUNX3 methylation status predicted the risk of NMIBC progression independently of tumor stage. In conjunction with tumor grade, RUNX3 methylation status in patients with NMIBC strongly predicts disease progression. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183446</comments>
            <pubDate>Mon, 29 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5183446</guid>        </item>
        <item>
            <title>Lymphatic vessel invasion detected by the D2‐40 monoclonal antibody is an independent prognostic factor in node‐negative esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5161156&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22079</link>
            <description>ConclusionsLVI detected by D2‐40 staining was an independent prognostic factor in patients with node‐negative ESCC. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5161156</comments>
            <pubDate>Sat, 27 Aug 2011 13:01:39 +0100</pubDate>
            <guid isPermaLink="false">5161156</guid>        </item>
        <item>
            <title>Poor prognostic factors in patients with stage I gastric cancer according to the seventh edition TNM classification: A comparative analysis of three subgroups</title>
            <link>http://www.medworm.com/index.php?rid=5161158&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22082</link>
            <description>ConclusionsSurvival data support the accuracy of new TNM classification for stage I gastric cancer. Tumor stage, the presence of LBVI and PNI are important independent prognostic factors in stage I gastric cancer. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5161158</comments>
            <pubDate>Tue, 23 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5161158</guid>        </item>
        <item>
            <title>Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger</title>
            <link>http://www.medworm.com/index.php?rid=5161157&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22084</link>
            <description>ConclusionsGC tends to exhibit more aggressive tumor behavior in young patients than in old patients; however, the surgical survival of young and old patients was similar. Advanced nodal involvement (N3) is the most important independent prognostic factor in the young. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5161157</comments>
            <pubDate>Tue, 23 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5161157</guid>        </item>
        <item>
            <title>Increased expression of insulin‐like growth factor‐1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma</title>
            <link>http://www.medworm.com/index.php?rid=5161164&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22077</link>
            <description>ConclusionsIGF‐1R is an independent prognostic marker for osteosarcoma patients and increased expression of this molecular is correlated with metastasis of osteosarcoma. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5161164</comments>
            <pubDate>Sun, 21 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5161164</guid>        </item>
        <item>
            <title>MiR‐142‐3p as a potential prognostic biomarker for esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5161163&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22066</link>
            <description>ConclusionThe main findings suggest that miR‐142‐3p is involved in the progression of ESCC and is a potential prognostic biomarker for ESCC. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5161163</comments>
            <pubDate>Sun, 21 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5161163</guid>        </item>
        <item>
            <title>Is a level III dissection necessary for a positive sentinel lymph node in melanoma?</title>
            <link>http://www.medworm.com/index.php?rid=5161162&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22076</link>
            <description>ConclusionsThe complication rate and regional recurrence rate for patients undergoing a level I/II ALND for a positive SLN are either lower than or on par with reported series of ALND for level I, II, and III dissections, suggesting that in this setting, the level III dissection may be of minimal benefit. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5161162</comments>
            <pubDate>Sun, 21 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5161162</guid>        </item>
        <item>
            <title>The impact of recurrent laryngeal neuromonitoring on multi‐dimensional voice outcomes following thyroid surgery</title>
            <link>http://www.medworm.com/index.php?rid=5161161&amp;cid=s_33654_6_f&amp;fid=33654&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjso.22063</link>
            <description>ConclusionIn this study, recurrent laryngeal neuromonitoring did not appear to influence non‐RLN injury related VO as measured by a comprehensive multidimensional voice assessment. J. Surg. Oncol © 2011 Wiley‐Liss, Inc. (Source: Journal of Surgical Oncology)</description>
            <author>Journal of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5161161</comments>
            <pubDate>Sun, 21 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5161161</guid>        </item>
    </channel>
</rss>

